Zobrazeno 1 - 10
of 13
pro vyhledávání: '"MARCIN STAJSZCZYK"'
Autor:
Bogdan Batko, Slawomir Jeka, Piotr Wiland, Agnieszka Zielińska, Maria Stopińska-Polaszewska, Marcin Stajszczyk, Magdalena Kosydar-Piechna, Mary Jane Cadatal, Jose L. Rivas
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 5, Pp 1217-1235 (2024)
Abstract Introduction In ORAL Surveillance, incidence rates (IRs) of major adverse cardiovascular events (MACE) and malignancies (excluding non-melanoma skin cancer [NMSC]) in cardiovascular (CV)-risk-enriched patients with rheumatoid arthritis (RA)
Externí odkaz:
https://doaj.org/article/8b3daa8c9bbd4da58e1330c0d2aa0e16
Autor:
Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko, Maria Maślińska, Marcin Stajszczyk, Jerzy Świerkot, Piotr Wiland, Zbigniew Żuber, Krzysztof Tomasiewicz
Publikováno v:
Rheumatology, Vol 62, Iss 1, Pp 4-17 (2024)
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolves, infection management in vulnerable populations requires formalized guidance. Although low-virulence variants of SARS-CoV-2 remain predominant, they pose an increased risk of sev
Externí odkaz:
https://doaj.org/article/fa76452fc1704c79a7e4b3c588653f23
Autor:
Anna Felis-Giemza, Mateusz Moskal, Krzysztof Proc, Zbigniew Guzera, Marcin Stajszczyk, Karolina Palej, Kornelia Chmurzyńska, Piotr Wiland, Krzysztof Batko, Bogdan Batko
Publikováno v:
Rheumatology, Vol 61, Iss 6, Pp 414-423 (2024)
Introduction This multicenter, real-world, retrospective cohort study aimed to assess the effectiveness and safety of tofacitinib (TOFA) in rheumatoid arthritis (RA). Material and methods Two hundred nine patients with active RA treated with TOFA, u
Externí odkaz:
https://doaj.org/article/1a3e8aa06ebc46cd924fc321a39006e6
Autor:
Marcin Stajszczyk, Grażyna Świerkowska, Katarzyna Smolik, Izabela Domysławska, Karol Charkiewicz, Włodzimierz Samborski
Publikováno v:
Rheumatology, Vol 61, Iss 5, Pp 331-338 (2023)
Introduction A widely accepted treat-to-target strategy for rheumatoid arthritis (RA) requires the patient’s perspective in making treatment decisions. However, data on treatment preferences and expectations of Polish patients with RA are scarce. T
Externí odkaz:
https://doaj.org/article/2bda2bec105f4b26b306308e93bbe379
Autor:
ERNEST KUCHAR, JOANNA CHOROSTOWSKA-WYNIMKO, LESZEK CZUPRYNIAK, ANDRZEJ FAL, ROBERT FLISIAK, ARTUR MAMCARZ, ANETA NITSCH-OSUCH, ANNA SKOCZYŃSKA, MARCIN STAJSZCZYK, JACEK WYSOCKI, MICHAŁ ABENDROT, DOMINIK GOLICKI, KATARZYNA JAŚKOWIAK, ADAM ANTCZAK
Publikováno v:
Family Medicine & Primary Care Review, Vol 25, Iss 1, Pp 93-101 (2023)
Pneumococcal infections (Streptococcus pneumoniae) remain a significant epidemiological problem globally. Although an invasive pneumo-coccal disease (IPD), which includes meningitis, sepsis and pneumonia with bacteremia, is the most severe form of pn
Externí odkaz:
https://doaj.org/article/aef1269d67464d969482ee413164b566
Publikováno v:
Rheumatology, Vol 60, Iss 2, Pp 92-100 (2022)
Externí odkaz:
https://doaj.org/article/aa2b9842e8374f5b98ea9d61ded79700
Autor:
Bogdan Batko, Marcin Stajszczyk, Jerzy Świerkot, Karol Urbański, Filip Raciborski, Mariusz Jędrzejewski, Piotr Wiland
Publikováno v:
Archives of Medical Science, Vol 15, Iss 1, Pp 134-140 (2018)
Introduction There are no reliable data regarding the prevalence of rheumatoid arthritis (RA) in Poland. Material and methods The first stage was a face-to-face survey on a nationwide representative sample of 3000 people, which identified respondent
Externí odkaz:
https://doaj.org/article/c69b933a32e34869b94e689e6feb3afb
Autor:
Bogdan Batko, Sławomir Jeka, Piotr Wiland, Marek Brzosko, Włodzimierz Samborski, Marcin Stajszczyk, Jerzy Chudek, Zbigniew Żuber
Publikováno v:
Polish archives of internal medicine. 132(9)
Achieving remission or lowdisease activity (LDA) is an integral principle of treat‑to‑target (T2T) strategy in rheumatoid arthritis (RA). Prior studies have reported that achieving T2T therapeutic goals may be realistic only for a fraction of pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8efc0b014b2b885c5aec8aa96e18296
https://pubmed.ncbi.nlm.nih.gov/35420283
https://pubmed.ncbi.nlm.nih.gov/35420283
Autor:
Marcin, Stajszczyk
Publikováno v:
Polskie Archiwum Medycyny Wewnetrznej. 108(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e2f52841bfb4964ef364e078b49fe947
https://pubmed.ncbi.nlm.nih.gov/12600190
https://pubmed.ncbi.nlm.nih.gov/12600190
Autor:
Marcin, Stajszczyk
Publikováno v:
Przeglad lekarski. 59(1)
Bisphosphonates are the most potent class of antiresorpitve drugs used in the treatment of bone diseases with enhanced resorption, like malignant osteolysis, osteoporosis and Paget's disease. Multiple myeloma is commonly associated with skeletal morb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d4d652621c197996a65b5ed0b4f70244
https://pubmed.ncbi.nlm.nih.gov/12108045
https://pubmed.ncbi.nlm.nih.gov/12108045